XSWX
VBSN
Market cap383mUSD
Jul 09, Last price
130.00CHF
1D
-1.52%
1Q
-7.14%
Jan 2017
-35.87%
IPO
52.85%
Name
IVF Hartmann Holding AG
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Neuhausen am Rheinfall, Switzerland, IVF Hartmann Holding AG is a global supplier of medical consumer products. Its extensive portfolio encompasses disposable items for surgical use, including instruments, blankets, clothing, and gloves, alongside solutions for disinfection, hygiene, wound management (featuring hydrotherapy services), incontinence care, and first aid. The company also offers a variety of educational courses. IVF Hartmann caters to a broad spectrum of clients, such as private medical practitioners, outpatient facilities, hospitals, clinics, pharmacies, drugstores, nursing homes, medical and food retail outlets, and various industrial sectors. Established in 1874, the company was initially known as IVF before adopting its current name, IVF Hartmann Holding AG, in 1993. It operates as a subsidiary of Paul Hartmann Finance B.V.
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||